Advertisement
Research Article

Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome

  • Alison Beaumont,

    Affiliation: School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia

    X
  • Alexander R. Burton,

    Affiliation: School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia

    X
  • Jim Lemon,

    Affiliation: School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia

    X
  • Barbara K. Bennett,

    Affiliations: School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia, Department of Medical Oncology, Prince of Wales Hospital, Sydney, New South Wales, Australia

    X
  • Andrew Lloyd,

    Affiliation: Inflammation and Infection Research Centre, School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia

    X
  • Uté Vollmer-Conna mail

    ute@unsw.edu.au

    Affiliation: School of Psychiatry, University of New South Wales, Sydney, New South Wales, Australia

    X
  • Published: November 14, 2012
  • DOI: 10.1371/journal.pone.0049518

Reader Comments (4)

Post a new comment on this article

Difficulties in interpreting research

Posted by kelly1 on 11 Jan 2013 at 19:02 GMT

This study demonstrates some of the construct difficulties in researching this disease.

Myalgic encephalomyelitis (chronic fatigue syndrome) has a number of transdiagnostic symptoms. A common caveat with any medical population is that symptoms that commonly occur with disease, including fatigue or loss of energy, changes in sleep patterns and cognitive difficulties, may be misinterpreted by healthcare providers, researchers or patients as mood-related particularly when specificity and severity are lacking.

As well, many of the instruments used to diagnose mood disorders can become a confounding variable in medical studies. (Jason et al 2012) So might the failure to separate patients with psychosocial overlays from patients without depression or anxiety as well as differentiating between patients with pre-morbid psychiatric illness and patients without.

As well, there are multiple definitions used under these umbrella terms that define very different populations ranging from the very heterogeneous (White et al 1991) to the narrowly defined (Caruthers 2011) some of which may include patients with mood disorders only (Jason et al 2012). This may limit extrapolation of results between groups.

A search of the literature reveals demonstrated cognitive symptoms in ME and CFS including processing-speed deficits and working memory impairment - which are also found in MS for example. (Tiersky et al 1997; DeLuca et al 1997, 2004; Busichio et al 2004; Lange et al 2005).

No competing interests declared.